Crucial role of selenium in the virucidal activity of benzisoselenazol- 3(2h)-ones and related diselenides

Article abstract of DOI:10.3390/molecules15118214

Various N-substituted benzisoselenazol-3(2H)-ones and their non-seleniumcontaining analogues have been synthesized and tested against selected viruses (HHV-1, EMCV and VSV) to determine the extent to which selenium plays a role in antiviral activity. The data presented here show that the presence of selenium is crucial for the antiviral properties of benzisoselenazol-3(2H)-ones since their isostructural analogues having different groups but lacking selenium either did not show any antiviral activity or their activity was substantially lower. The open-chain analogues of benzisoselenazol- 3(2H)-ones-diselenides also exhibited high antiviral activity while selenides and disulfides were completely inactive towards model viruses.

Full text of DOI:10.3390/molecules15118214

Molecules 2010, 15, 8214-8228; doi:10.3390/molecules15118214
OPEN ACCESS
molecules
ISSN 1420-3049
www.mdpi.com/journal/molecules
Article
Crucial Role of Selenium in the Virucidal Activity of
Benzisoselenazol-3(2H)-ones and Related Diselenides
Magdalena Pietka-Ottlik 1,*, Piotr Potaczek 1, Egbert Piasecki 2 and Jacek Mlochowski 1
1
Faculty of Chemistry, Wroclaw University of Technology, Wybrzeze Wyspianskiego 27, 50-370
Wroclaw, Poland; E-Mails: piotr.potaczek@pwr.wroc.pl (P.P.);
jacek.mlochowski@pwr.wroc.pl (J.M.)
2
Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, R. Weigla 12,
53-114 Wroclaw, Poland.; E-Mail: piasecki@iitd.pan.wroc.pl (E.P.)
* Author to whom correspondence should be addressed; E-Mail: magdalena.pietka@pwr.wroc.pl;
Tel.: +48-71-320-24-23; Fax: +48-71-328-40-64.
Received: 29 October 2010; in revised form: 5 November 2010 / Accepted: 9 November 2010 /
Published: 12 November 2010
Abstract: Various N-substituted benzisoselenazol-3(2H)-ones and their non-selenium-
containing analogues have been synthesized and tested against selected viruses (HHV-1,
EMCV and VSV) to determine the extent to which selenium plays a role in antiviral
activity. The data presented here show that the presence of selenium is crucial for the
antiviral properties of benzisoselenazol-3(2H)-ones since their isostructural analogues
having different groups but lacking selenium either did not show any antiviral activity or
their activity was substantially lower. The open-chain analogues of benzisoselenazol-
3(2H)-ones—diselenides also exhibited high antiviral activity while selenides and
disulfides were completely inactive towards model viruses.
Keywords: organoselenium compounds; organosulfur compounds; isoindolin-1-ones;
ebselen; antiviral activity
1. Introduction
Over the last years, selenium-containing compounds have been proven to be promising
antioxidants, enzyme mimics and inhibitors, immunomodulators, cytoprotectors, antitumor, anti-

Molecules 2010, 15
8215
inflammatory, antihypertensive and antiinfectious agents [1]. Recently, considerable interest has been
directed towards the antiviral properties of organoselenium compounds and in consequence some
highly active benzisoselenazol-3(2H)-ones and diselenides have been successfully developed [2-4].
However, the mechanism of their antiviral action still remains unclear.
In our study we wanted to determine whether selenium is crucial for antiviral properties of
benzisoselenazol-3(2H)-ones 1. For this purpose various N-substituted benzisoselenazol-3(2H)-ones 1
and their non-selenium-containing analogues 2-4 have been synthesized and tested in vitro against
selected viruses (HHV-1 human herpes virus type 1, EMCV Encephalomyocarditis virus and VSV
Vesicular stomatitis virus) (Figure 1). Since it is believed that the cleavage of the Se-N bond in
benzisoselenazol-3(2H)-ones by thiols is responsible for their biological activity [1], we have
compared the antiviral activity of benzisoselenazol-3(2H)-ones 1 and their analogues 5 that have the
Se-C bond instead of the Se-N one to further understand the role of selenium in antivirals.
The second objective of our study was to compare the antiviral activity of benzisoselenazol-3(2H)-
ones 1 and corresponding diselenides 6 and selenides 8. Based on the circumstance that the antiviral
properties of organoselenium compounds could be due to their ability to react with thiols we
envisioned that diselenides which are open-chain analogues of benzisoselenazol-3(2H)-ones may also
exhibit antiviral activity, while disulfides and selenides should be inactive. However, the antiviral
activity of corresponding benzisoselenazol-3(2H)-ones and diselenides do not necessarily have to be
the same value. Recently it has been shown that amide-based diselenides do not react with thiols as
readily as e.g. amine-based diselenides do [5,6].
Figure 1. General formulas of tested compounds 1–8.
CONHR
O
O
N
R
Z
R
Y
X
Se
1 - 4
1, 5
RHNOC
X=Se (1); X=S (2); X=CH2 (3); X=CO (4)
R=H (a), Me (b), Et (c), n-Pr (d), n-Bu (e),
n-C12H25 (f), Ph (g), 2-Py (h), N(Ph)2 (i), Bn (j)
Z=N (1); Z=CH (5);
6 - 8
R=COMe (k), COOEt (l)
Y=Se-Se (6); Y=S-S (7); Y=Se (8);
R=H (a), Me (b), Et (c), n-Pr (d),
n-Bu (e), Ph (f), Bn (g)
2. Results and Discussion
2.1. Synthesis
The N-substituted benzisoselenazol-3(2H)-ones 1 have been prepared by the selenenylation-
acylation of primary amines with 2-(chloroseleno)benzoyl chloride (11), obtained in a four-step
synthesis starting from anthranilic acid (9), same way as reported in our previous works [3,4,7,8]. The
same reaction of chloride 11 with corresponding CH-acids produced desired 3-hydroxybenzo[b]-
selenophenes, which are more stable forms of benzo[b]selenophen-3(2H)-ones 5 (Scheme 1) [9,10].

Molecules 2010, 15
Scheme 1. Synthesis of benzisoselenazol-3(2H)-ones (1) and related compounds.
8216
Reagents and Conditions: i. 1) NaNO 2, HCl, H 2O, 0-5 ºC; 2) Li 2Se 2, NaOH aq, -5-0 ºC; 3) HCl; ii.
SOCl 2 (excess), DMF (cat.), reflux; iii. SOCl 2, reflux; iv. Cl2, CCl4, rt; v. Cl2P(Ph) 3, MW (400W),
5 min; vi. R-NH 2, CH2Cl2 or MeCN (X=Se); vii. R-NH 2, CH2Cl2, -15 ºC (X=S); viii. 1) R-NH 2, Et
3N, CH2Cl2, rt, 2)DBU, rt (X=CH 2); ix. N2H4, EtOH, reflux, x. 1) Zn, NaOH; 2) o-I-C 6H 4-COOH,
K 2CO 3, Cu; xi. 1) SOCl 2, benzene, reflux; 2) R-NH 2, CH2Cl2 or MeCN; xii. R-NH 2, CH2Cl2
or MeCN.
For the synthesis of N-substituted benzisothiazol-3(2H)-ones 2 the analogous reaction of
2-(chlorosulfanyl)benzoyl chloride (12), obtained in a two-step synthesis starting from 2,2’-
dithiodibenzoic acid (14) [11], with corresponding primary amines has been adapted. This reaction has
already been successfully used with some primary amines [12], hydrazine derivatives [13] and amino
acids [14,15] as reactants. Our further studies have demonstrated that the reactions of chloride 12 with
other N-nucleophiles, e.g., thiourea, thioacetamide, acetamide and p-methylbenzenesulfonamide also
resulted in N-substituted benzisothiazol-3(2H)-ones, while reactions with CH-acids gave corresponding
benzo[b]thiophen-3(2H)-ones or/and 3-hydroxybenzo[b]thiophenes [16]. 2,2’-Dithiodibenzoyl chloride
(15) has been used to obtain various N-substituted disulfides 7 in the reaction with primary amines.
Since several ortho-disubstituted benzenes with both substituents being of electrophilic character,
among them the abovementioned 2-(chloroseleno)benzoyl chloride (11) and 2-(chlorosulfanyl)benzoyl
chloride (12), readily reacted with bisnucleophiles such as primary amines or activated methylene
compounds to form a five-membered heterocyclic ring annulated onto the benzene moiety in a one-pot
reaction, we decided to apply this approach to synthesize isoindolin-1-ones 3 (phthalimidines) as well.
Although several synthetic approaches to particular isoindolin-1-ones have already been known, only a
few of them such as reduction of one carbonyl group in phthalimides with zinc in acetic acid [17,18]
or reaction of phthalide with primary amines, mostly under elevated pressure [19], are more general.
The attempts to obtain N-substituted isoindolin-1-ones 3 by direct reaction of chloride 13 with primary
amines were unsuccessful, because only N-acylation took place while the chloromethyl group
remained unreactive [20,21]. The only exception was 2-(chloromethyl)-N-methylbenzamide, obtained

Molecules 2010, 15
8217
from methylamine, that underwent cyclization to the corresponding N-methylisoindolin-1-one when
treated with LDA at -78 °C [21]. In our study we have found that 2-(chlorophenyl)benzamide obtained
from 2-(chloromethyl)benzoyl chloride (13) and aniline, treated with DBU easily cyclized to N-
phenylisoindolin-l-one (3g) in almost quantitative yield. The same compound 3g was obtained in one-
pot procedure involving tandem acylation-alkylation of primary amines with 2-(chloromethyl)benzoyl
chloride obtained from commercially available isobenzofuran-1(3H)-one treated with
triphenylphosphine dichloride under microwave conditions (which allowed us to reduce the reaction
time from 6 h to 5 min). Chloride 13 and aniline reacted in the presence of triethylamine for 2 h at
room temperature and then DBU was added to the mixture and the reaction was continued for
additional 2 h. This one-pot procedure was successfully extended on other N-substituted isoindolin-1-
ones which were formed in good or moderate yields. Gaseous methylamine passed through the
solution of chloride 13 in dichloromethane gave directly (without DBU) N-methylisoindolin-1-one
(3b) while the reaction of 13 with gaseous ammonia led to the mixture of unstable compounds.
Nevertheless unsubstituted isoindolin-1-one 3a was obtained in moderate yield in a one-pot procedure
involving alkoxylation of the chlorocarbonyl group of 13 to a carboxyester group, followed by
acylation-alkylation of ammonia.
While the one-pot reaction of 2-(chloromethyl)benzoyl chloride (13) with amines in the presence of
DBU was convienient for the synthesis of isoindolin-1-ones, the analogous reaction with CH-acids did
not lead to expected cyclic 2,2-disubstituted 2,3-dihydroinden-1-ones and in all cases only acylation
products were formed.
N-substituted phtalimides 4 have been prepared using standard procedures. Alkyl derivatives have
been obtained in the reaction of potassium phtalimide with alkyl halides and phenyl phthalimide by
heating phthalic anhydride and aniline.
The strategy for the synthesis of N-substituted bis(2-carbamoyl)phenyl diselenides 6 has been based
on the reductive cleavage of the Se-N bond in corresponding benzisoselenazol-3(2H)-ones [7]. The
selenides 8 have been prepared by the treatment of bis(2-chlorocarbonylphenyl) selenide, obtained
from bis(2-carboxyphenyl) selenide 17, with primary amines.
2.2. Virucidal Activity
The virucidal activity of compounds 1-8 has been determined in vitro towards HHV-1 (human
herpes virus type 1, Herpesviridae, enveloped virus), EMCV (encephalomyocarditis virus,
Picornaviridae, non-enveloped virus) and VSV (vesicular stomatitis virus, Rhabdoviridae, enveloped
virus). The virus titer has been measured in human cell line A549 and the minimal inhibitory
concentration MIC (μg/mL) has been determined. In the virucidal activity assay, compounds have been
used in the non-toxic concentrations. The cytotoxicity of compounds has been assessed in the same
tumor cell line (A549). The results are summarized in Tables 1–3.

Molecules 2010, 15
8218
Table 1. Comparison of the virucidal activity of benzisoselenazol-3(2H)-ones 1 and their
isostructural analogues 2–4.
Compounds
MICHHV-1
MICEMCV
MICVSV
1 - 4
X
Se
S
CH2
C=O
Se
S
CH2
C=O
Se, S
CH2
C=O
R
H
Me
Et
n-Pr
n-Bu
n-C12H25
Ph
2-Py
8
8
8
6
6
4
4
4
6
2
>1000
100
400
100
80
600
80
>1000
400
60
>1000
>1000
ND
>1000
ND
>1000
>1000
ND
>1000
ND
ND
>1000
ND
4
4
4
6
6
>1000
>1000
>1000
>1000
>1000
>1000
>1000
ND
>1000
ND
>1000
>1000
ND
>1000
ND
ND
>1000
ND
>1000
>1000
>1000
>1000
>1000
>1000
>1000
>1000
>1000
>1000
>1000 >1000
>1000 >1000
ND
ND
>1000 >1000
ND
ND
ND
ND
ND
>1000 >1000
10 >1000
>1000 >1000
>1000 >1000
ND
>1000
>1000
>1000
>1000
>1000
>1000
>1000
>1000
>1000 >1000
>1000
>1000
>1000
ND
ND
ND
ND
N(Ph)2
Bn
ACV
ND
ND
ND
ND
6
>1000
>1000*
ND
MIC – Minimal Inhibitory Concentration (µg/mL); ACV – acyclovir; ND – not determined;
*Acyclovir was inactive in virucidal assay, but it inhibited viral replication at 20 µg/mL.
From Table 1, it is evident that benzisoselenazol-3(2H)-ones 1 are much better antivirals than their
non-selenium-containing analogues 2–4. The majority of tested benzisoselenazol-3(2H)-ones 1
exhibited high antiviral activity towards HHV-1 (MIC in a range of 2.0-8.0 μg/mL) and EMCV (MIC
in a range of 4.0-10.0 μg/mL) whereas their analogues either were completely inactive
(MIC >1000 μg/mL for isoindolin-1-ones 3 and phtalimides 4) or their activity was substantially lower
(MIC in range of 80-1000 μg/mL for benzisothiazol-3(2H)-ones 2) than the corresponding organo-
selenium compounds. This clearly indicates that selenium plays crucial role in antiviral activity of
benzisoselenazol-3(2H)-ones 1. To verify whether this activity could be due to the presence of the
labile Se-N bond, the antiviral activity of benzisoselenazol-3(2H)-ones and their analogues having the
Se-C bond has been compared (Table 2). 3-Hydroxybenzo[b]selenophenes (more stable forms of
benzo[b]selenophen-3(2H)-ones 5) have been found to be inactive towards tested viruses
(MIC >1000 μg/mL) while the corresponding benzisoselenazol-3(2H)-ones (1k, 1l) exhibited high
activity against HHV-1 and EMCV (MIC in a range of 4.0-10.0 μg/mL) ) and low activity against
VSV (MIC = 600 μg/mL). Thus, it can be supposed that antiviral activity similarly to other biological
activities of benzisoselenazol-3(2H)-ones is related to the presence of the Se-N bond which can
undergo cleavage.
Table 2. Comparison of the virucidal activity of benzisoselenazol-3(2H)-ones 1 and their
analogues having the Se-C bond instead of the Se-N bond 5.
Compounds
MICHHV-1
CH
MICEMCV
MICVSV
CH
1, 5
Z
N
4
N
6
CH
N
R
COMe
>1000
>1000
>1000
>1000
600
600
>1000
>1000
COOEt
10
10
MIC = Minimal Inhibitory Concentration (μg/mL).

Molecules 2010, 15
8219
The majority of tested diselenides 6 exhibited virucidal activity towards HHV-1 and EMCV in the
same range that corresponding benzisoselenazol-3(2H)-ones 1 (MIC in a range of 2.0-10.0 μg/mL).
Only two diselenides 6f, 6g have been found inactive against EMCV. Like the benzisoselenazol-
3(2H)-ones, none of tested diselenides exbibited antiviral activity against VSV. The replacement of the
Se-Se bond in diselenides by the S-S one resulted in complete loss of antiviral activity. The
corresponding selenides 8 have been found completely inactive against all tested viruses as well (Table
3). A comparison of antiviral activity of diselenides 6 and their abovementioned analogues 7, 8 reveals
that also in this case their activity can be due to the reaction with biologicaly important thiols.
However, it is not confirmed in this case whether they are able to react directly with thiols or e.g. in the
first step their cyclic analogues are formed to be active forms.
Table 3. Comparison of the virucidal activity of diselenides 6, disulfides 7 and selenides 8.
Compounds
MICHHV-1
MICEMCV
MICVSV
6 - 8
Y
Se_Se
10
2
S_S
Se
Se_Se
6
S_S
Se
Se_Se
S_S
Se
R
H
Me
Et
>1000 >1000
>1000 >1000
>1000 >1000 >1000 >1000 >1000
>1000 >1000 >1000 >1000 >1000
6
2
>1000
>1000 >1000
>1000 ND
ND
4
>1000
>1000 >1000 >1000 >1000 >1000
>1000 ND >1000 >1000 ND
ND
>1000 >1000
ND
n-Pr
n-Bu
Ph
6
40
100
10
20
8
>1000 >1000 >1000 >1000 >1000 >1000 >1000 >1000
Bn
>1000
>1000*
ND
>1000 >1000
ND
ND
>1000 >1000
ND
ND
ACV
MIC = Minimal Inhibitory Concentration (μg/mL); ACV – acyclovir; ND – not determined;
*Acyclovir was inactive in virucidal assay, but it inhibited viral replication at 20 μg/mL.
3. Experimental
3.1. General
All reagents and solvents were purchased from Sigma-Aldrich or Fluka. Melting points were
determined in open glass capillaries with an Electrothermal IA 9100 digital melting point apparatus. IR
spectra were measured on a Perkin Elmer 2000 FT-IR spectrophotometer in KBr pellets or in thin
1
13
films and peaks are reported in cm-1. Only representative absorptions are given. H-NMR, C-NMR
and 77Se-NMR spectra were recorded in DMSO-d6 or CDCl3 on a 300 MHz Bruker DRX spectrometer
(1H-NMR, 13C-NMR) or a 600 MHz Bruker AVII spectrometer (77Se-NMR). Chemical shifts are
reported in ppm relative to TMS or dimethyl selenide. Reaction progress was monitored by a thin layer
chromatography (TLC) on silica gel 60F254 coated aluminium TLC plates from Merck.
3.2. Benzisoselenazol-3(2H)-ones (1)
The synthesis and properties of compounds 1a–g [4], 1l [4], 1h [3], 1j [22] and 1k [23] are given in
references cited. Melting points and spectra were identical with the reported data.

Molecules 2010, 15
8220
2-(N,N-Diphenylamino)benzisoselenazol-3(2H)-one (1i). A solution of chloride 11 (1.27 g, 5.00 mmol)
in dry dichloromethane (50 mL) was added dropwise over 30 min to a stirred solution of amine
hydrochloride (5.00 mmol) and triethylamine (1.67g, 16.50 mmol) in dry dichloromethane (50 mL) in
an ice/NaCl bath and the reaction was continued overnight, ending at room temperature. When the
reaction was complete, the solvent was evaporated in vacuo and the crystalline residue was treated
with water (100 mL) and stirred for 3 h. The insoluble solid was filtered off, washed with water and
dried in the air. Crude product was purified by chromatography on silica gel with chloroform as the
1
eluent and then recrystalized from ethyl acetate. 58% yield, yellow crystals, m.p. 154-156 °C, H-
NMR (DMSO-d6) δ: 7.06-7.09 (m, 6H, ArH), 7.34 (t, 4H, J = 7.9 Hz, ArH), 7.46 (t, 1H, J = 7.4 Hz,
77
ArH), 7.66-7.72 (m, 1H, ArH), 7.92 (d, 1H, J = 7.1 Hz, ArH), 8.04 (d, 1H, J = 8.0 Hz, ArH); Se-
NMR (DMSO-d6) δ: 865; νmax (KBr): 1633 (CO); Anal. Calcd for C19H14N2OSe: C, 62.47; H, 3.86; N,
7.67. Found: C, 62.46; H, 3.76; N, 7.62.
3.3. Benzisothiazol-3(2H)-ones 2
2-(Chlorosulfanyl)benzoyl chloride (12) has been obtained according to the procedure described in
references cited [11]. Benzisothiazol-3(2H)-ones 2a–c. Benzisothiazol-3(2H)-one (2a), 2-
methylbenzisothiazol-3(2H)-one (2b), 2-ethylbenzisothiazol-3(2H)-one (2c). General procedure: A
vigrously stirred and cooled on ice/NaCl bath solution of 2-(chlorosulfanyl)benzoyl chloride (12,
0.83 g, 4.00 mmol) in dry dichloromethane (30 mL) was saturated by corresponding dry gaseous
amine over 1 h. The reaction was continued for additional 1 h, finally in room temperature. After the
reaction has finished, the mixture was washed with 5% HCl (3 × 50 mL) and then with water
(2 × 50 mL). The organic layer was dried with anhydrous Na2SO4, the solvent was evaporated in vacuo
and the residue was purified by silica gel chromatography (chloroform, and then ethyl acetate). Yields
for 2a–c: 85%, 76% and 81%, respectively. The compounds 2a [24], 2b [25], 2c [26] are known
compounds and their properties were identical with those given in references cited.
Benzisothiazol-3(2H)-ones 2d–j. 2-n-Propylbenzisothiazol-3(2H)-one (2d), 2-n-butylbenzisothiazol-
3(2H)-one (2e), 2-n-dodecylbenzisothiazol-3(2H)-one (2f), 2-phenylbenzisothiazol-3(2H)-one (2g), 2-
(2-pyridyl)benzisothiazol-3(2H)-one (2h), 2-(N,N-diphenylamino)benzisothiazol-3(2H)-one (2i), 2-
benzylbenzisothiazol-3(2H)-one (2j). General procedure: To a stirred on ice/NaCl bath solution of
corresponding amine (16.50 mmol) for 2d–h, 2j or amine hydrochloride (5.00 mmol) and
triethylamine (1.67 g, 16.50 mmol) for 2i in dry dichloromethane (50 mL), a solution of chloride 12
(1.04 g, 5.00 mmol) in dry dichloromethane (50 mL) was dropped over 30 min. The reaction was
continued for additional 4-16 h. After then the solvent was evaporated in vacuo and the crystalline
residue was treated with water (100 mL) and stirred for 16 h. The insoluble solid was filtered off,
washed with water and dried in the air. Crude products were recrystalized from hexane (2f), ethyl
acetate (2g), methanol (2h, 2j) or purified by chromatography on silica gel with chloroform as the
eluent and then recrystalized from ethyl acetate (2d, 2e, 2i). Yields for 2d–j: 77%, 81%, 81%, 73%,
88%, 41%, 89% respectively. The compounds 2d [26], 2g [24,26], 2h [27] and 2j [24,26] are known
and their properties were in agreement with those given in references cited.

Molecules 2010, 15
8221
1
2-n-Butylbenzisothiazol-3(2H)-one (2e). 81% yield, yellow oil, H-NMR (CDCl3) δ: 0.96 (t, 3H,
J = 7.6 Hz, CH3), 1.40 (m, 2H, (CH2)2CH2CH3), 1.74 (m, 2H, CH2CH2 CH2CH3), 3.89 (t, 2H,
J = 7.6 Hz, CH2(CH2)2CH3), 7.38 (t, 1H, J = 7.8 Hz, ArH), 7.51-7.61 (m, 2H, ArH), 8.02 (d, 1H,
J = 8.0 Hz, ArH); 13C-NMR (CDCl3) δ: 13.7, 19.8, 31.6, 43.7, 120.3, 124.9, 125.4, 126.6, 131.6, 140,2,
165.3; νmax (film): 1660 (CO); Anal. Calcd for C11H13NOS: C, 63.74; H, 6.32; N, 6.76; S, 15.47.
Found: C, 63.82; H, 6,36; N, 6.74; S, 15.52.
1
2-n-Dodecylbenzisothiazol-3(2H)-one (2f). 81% yield, white crystals, m.p. 39-40 °C, H-NMR
(CDCl3) δ: 0.88 (t, 3H, J = 6.7 Hz, CH3), 1.26-1.35 (m, 18H, N(CH2)2(CH2)9CH3), 1.77 (m, 2H,
NCH2CH2(CH2)9CH3), 3.89 (t, 2H, J = 7.2 Hz, NCH2(CH2)10CH3), 7.40 (t, 1H, J = 6.7 Hz, ArH), 7.51-
13
7.62 (m, 2H, ArH), 8.04 (d, 1H, J = 7.8 Hz, ArH); C-NMR (CDCl3) δ: 14.1, 22.7, 26.6, 29.2, 29.2,
29.4, 29.5, 29.6, 31.9, 44.0, 120.3, 124.9, 125.4, 126.6, 131.6, 140.2, 165.3; νmax (KBr): 1662 (CO);
Anal. Calcd for C19H29NOS: C, 71.42; H, 9.15; N, 4.38; S, 10.04. Found: C, 71.48; H, 9.12; N, 4.44; S,
10.10%.
2-(N,N-Diphenylamino)benzisothiazol-3(2H)-one (2i). 41% yield, pale beige needles, m.p. 130 °C
(decomp.), 1H-NMR (DMSO-d6) δ: 7.06-7.15 (m, 6H, ArH), 7.37 (t, 4H, J = 7.8 Hz, ArH), 7.48 (t, 1H,
J = 7.5 Hz, ArH), 7.77 (t, 1H, J = 7.6 Hz, ArH), 7.95-8.00 (m, 2H, ArH); νmax (KBr): 1680 (CO); Anal.
Calcd for C12H8N2OS: C, 71.67; H, 4.43; N, 8.80; S, 10.07. Found: C, 71.61; H, 4.26; N, 8.73;
S, 10.90.
3.4. Isoindolin-1-ones 3
For the preparation of 2-(chloromethyl)benzoyl chloride (13) a vigorously stirred cooled on
ice/NaCl bath solution of triphenylphosphine (26.23g, 0.10 mol) in dry dichloromethane (50 mL) was
saturated by dry chlorine. Reaction progress was monitored by TLC. After the reaction has finished,
isobenzofuran-1(3H)-one (13.41g, 0.10 mol) was added. The reaction was continued in microwave
(5 min, 400 W). 2-(Chloromethyl)benzoyl chloride (13) was distilled off in vacuo from the reaction
mixture (120 ºC/ 2 mmHg) as colourless oil. Yield 66%. Spectral data (1H-NMR, IR) were the same as
these reported in the reference cited [28].
Isoindolin-1-one (3a). A solution of 2-(chloromethyl)benzoyl chloride (13, 0.94 g, 5.00 mmol) in
ethanol (20 mL) was heated under reflux for 1 h. A solution of ammonia (20 mL) was added and the
reaction was continued for an additional 1 h. After the reaction has finished the reaction mixture was
extracted with dichloromethane (3 × 30 mL). The combined extracts were dried with anhydrous
Na2SO4, the solvent was evaporated in vacuo and the residue was recrystalized from hexane-
chloroform as white needles. Yield 35%.
2-Methylisoindolin-1-one (3b). A vigorously stirred solution of 2-(chloromethyl)benzoyl chloride (13,
0.94 g, 5.00 mmol) in dry dichloromethane (50 mL) cooled in an ice/NaCl bath was saturated by dry
methylamine over 30 min. The reaction was continued for additional 24 h, finally in the room
temperature. After the reaction has finished, dichloromethane was evaporated in vacuo and from the

Molecules 2010, 15
8222
residue product was separated by silica gel chromatography (dichloromethane) and then recrystalized
from hexane as white needles. Yield 74%.
Isoindolin-1-ones 3d, 3g–j. 2-n-Propylisoindolin-1-one (3d), 2-phenylisoindolin-1-one (3g), 2-(2-
pyridyl)isoindolin-1-one (3h), 2-(N,N-diphenylamino)isoindolin-1-one (3i), 2-benzylisoindolin-1-one
(3j). General procedure: To a stirred solution of amine (5.50 mmol) and triethylamine (0.56 g, 5.50
mmol) in dry dichloromethane (30 mL) the solution of chloride 13 (0.94 g, 5.00 mmol) in dry
dichloromethane (20 mL) was added dropwise at room temperature for 30 min. After additional 2 h,
DBU (1.54 g, 10.10 mmol) was added. The reaction was continued for additional 2 h at room
temperature. After the reaction has finished, dichloromethane was evaporated in vacuo and the residue
was separated by silica gel chromatography (dichloromethane) and then recrystalized from hexane-
chloroform (3d, 3i, 3j), acetonitrile (3h) or hexane-ethyl acetate (3g). Yields for 3d, 3g–j: 61%, 69%,
60%, 65% and 59%, respectively.
The compounds 3a [29], 3b [30], 3d [31], 3g [32], 3h [33], 3j [32] are known and their properties
were in agreement with those given in references cited.
1
2-(N,N-diphenylamino)isoindolin-1-one (3i). 65% yield, white needles, m.p. 168-170 °C, H-NMR
(CDCl3) δ: 4.64 (s, 2H, CH2), 7.03-7.08 (m, 2H, ArH), 7.10-7.16 (m, 4H, ArH), 7.26-7.32 (m, 4H,
ArH), 7.45 (d, 1H, J = 7.5 Hz, ArH), 7.51 (t, 1H, J = 7.3 Hz, ArH), 7.61 (dt, 1H, J = 6.3 and 1.2 Hz,
ArH), 7.94 (d, 1H, J = 7.5 Hz, ArH); 13C-NMR (CDCl3) δ: 48.10, 119.81, 123.27, 123.40, 124.60,
128.38, 129.49, 131.07, 132.32, 139.72, 144.50, 166.86; νmax (KBr): 1705 (CO); Anal. Calcd for
C20H16N2O: C, 79.98; H, 5.37; N, 9.33. Found: C, 80.01; H, 5.39; N, 9.42.
3.5. Phthalimides 4
Compound 4a was commercially available (Sigma). It was used after recrystallization from ethanol.
Phthalimides 4b, 4d. N-Methylphthalimide (4b), N-n-propylphthalimide (4d). General procedure:
Potassium phthalimide (0.93 g; 5.00 mmol), alkyl iodide in excess and DMF (5 mL) were heated in
reflux for 1h. Then the mixture was poured into water (30 mL) and extracted with dichloromethane
(3 × 10 mL). After evaporating of the solvent, the crude product was recrystalized from methanol (4b)
or ethanol (4d). Yields for 4b, 4d: 80%, 94%, respectively. Compounds 4b [34] and 4d [35] are known
and their properties were in agreement with those given in references cited.
N-Phenylphthalimide (4g). ortho-Phthalic anhydride (0.74 g; 5.00 mmol) and aniline (0.47 g;
5.00 mmol) were heated in acetic acid (10 mL) for 1h. Then the mixture was cooled down and the
insoluble product was filtered off, washed with water, dried and recrystallized from ethanol as
colourless needles. Yield 74%. The chemical properties were in agreement with those given in
references cited [36].

Molecules 2010, 15
8223
3.6. 3-Hydroxybenzo[b]selenophenes 5
The synthesis and properties of compounds 5k [9] and 5l [10] are given in references cited. Melting
points and spectra were identical with the reported data.
3.7. Diselenides (6)
The synthesis of diselenides 6a–g was carried out according to ref. [7]. The compounds 6a [7], 6b
[7], 6f [7] and 6g [37] were previously reported and their properties were in agreement with those
given in references cited.
1
Bis[2-(N-ethylcarbamoyl)phenyl] diselenide (6c). 79% yield, white powder, m.p. 210-212 °C, H-
NMR (DMSO-d6) δ: 1.17 (t, 6H, J = 7.2 Hz, 2 × CH3), 3.30-3.38 (m, 4H, 2 × CH3), 7.29-7.40 (m, 4H,
ArH), 7.69 (d, 2H, J = 7.5 Hz, ArH), 7.78 (dd, 2H, J = 7.4, 1.0 Hz, ArH), 8.71 (t, 2H, J = 4.9 Hz, NH);
77Se-NMR (DMSO-d6) δ: 455; Anal. Calcd for C18H20N2O2Se2: C, 47.59; H, 4.44; N, 6.17. Found: C,
47.86; H, 4.47; N, 6.14.
Bis[2-(N-n-propylcarbamoyl)phenyl] diselenide (6d). 79% yield, white powder, m.p. 223-224 °C, 1H-
NMR (DMSO-d6) δ: 0.93 (t, 6H, J = 7.4 Hz, 2 × CH3), 1.52-1.64 (m, 4H, 2 × CH2CH2CH3), 3.23-3.30
(m, 4H, 2 × CH2CH2CH3), 7.29-7.40 (m, 4H, ArH), 7.69 (d, 2H, J = 7.8 Hz, ArH), 7.78 (dd, 2H,
77
J = 7.4, 1.1 Hz, ArH), 8.71 (t, 2H, J = 5.3 Hz, NH); Se-NMR (DMSO-d6) δ: 455; Anal. Calcd for
C20H24N2O2Se2: C, 49.80; H, 5.02; N, 5.81. Found: C, 49.93; H, 4.98; N, 5.83.
1
Bis[2-(N-n-butylcarbamoyl)phenyl] diselenide (6e). 89% yield, white powder, m.p. 181-183 °C, H-
NMR (DMSO-d6) δ: 0.93 (t, 6H, J = 7.3 Hz, 2 × CH3), 1.31-1.43 (m, 4H, 2 × (CH2)2CH2CH3), 1.50-
1.60 (m, 4H, 2 × CH2CH2 CH2CH3), 3.26-3.33 (m, 4H, 2 × CH2(CH2)2CH3), 7.29-7.39 (m, 4H, ArH),
7.69 (d, 2H, J = 7.3 Hz, ArH), 7.77 (dd, 2H, J = 7.4, 1.1 Hz, ArH), 8.69 (t, 2H, J = 5.4 Hz, NH); 77Se-
NMR (DMSO-d6) δ: 455; Anal. Calcd for C22H28N2O2Se2: C, 51.77; H, 5.53; N, 5.49. Found: C, 51.84;
H, 5.52; N, 5.46.
3.8. Disulfides 7
The chloride 15 has been obtained according to the procedure described in references cited [11].
Disulfides 7a–g. Bis(2-carbamoylphenyl disulfide (7a), bis[2-(N-methylcarbamoyl)phenyl] disulfide
(7b), bis[2-(N-ethylcarbamoyl)phenyl] disulfide (7c), bis[2-(N-n-propylcarbamoyl)phenyl] disulfide
(7d), bis[2-(N-n-butylcarbamoyl)phenyl] disulfide (7e), bis[2-(N-phenylcarbamoyl)phenyl] disulfide
(7f), bis[2-(N-benzylcarbamoyl)phenyl] disulfide (7g). General procedure: To a stirred solution of
corresponding amine (8.80 mmol) in dry dichloromethane (25 mL), a solution of chloride 15 (0.69 g,
2.00 mmol) in dry dichloromethane (15 mL) was added dropwise over 30 min in room temperature.
After the reaction has finished the solvent was evaporated in vacuo and the crystalline residue was
treated with water (70 mL) and stirred for 4 h. The insoluble solid was filtered off, washed with water
and dried in the air. Crude products were recrystalized from dioxane (7a, 7b, 7f), ethanol (7c–e) or
ethyl acetate (7g). Yields for 7a–g: 87%, 59%, 61%, 73%, 85%, 87%, 63% respectively. The

Molecules 2010, 15
8224
compounds 7a [24], 7b [38], 7c–d [39], 7e [40] and 7f–g [39] are known and their properties were in
agreement with those given in references cited.
3.9. Selenides 8
The chloride of 17 has been obtained according to the procedure described in references cited [41].
Selenides 8a, 8b, 8d, 8f. General procedure: To a stirred solution of corresponding amine
(4.40 mmol) in dry acetonitrile (20 mL) (8a, 8b) or dichloromethane (20 mL) (8d, 8f), a solution of
chloride of 17 (0.36 g, 1.00 mmol) in dry acetonitrile (10 mL) (8a, 8b) or dichloromethane (10 mL)
(8d, 8f) was added dropwise over 30 min in room temperature. After the reaction has finished the
solvent was evaporated in vacuo and the residue was treated with water (70 mL) and stirred for 4 h.
The insoluble solid was filtered off, washed with water and dried in the air. Crude products were
recrystalized from ethanol.
Bis(2-carbamoylphenyl) selenide (8a). 89% yield, colourless crystals, m.p. 210-212 °C (ref. [41]
212-213 °C), 1H-NMR (DMSO-d6) δ: 7.22 (d, 2H, J = 7.2 Hz, ArH), 7.26-7.35 (m, 4H, ArH), 7.46 (bs,
2H, NH), 7.60 (d, 2H, J = 7.0 Hz, ArH), 7.94 (bs, 2H, NH); 77Se-NMR (DMSO-d6) δ: 448; νmax (KBr):
3347, 3278, 3215 (NH), 1670, 1652 (CO); Anal. Calcd for C14H12N2O2Se: C, 52.68; H, 3.79; N, 8.78.
Found: C, 51.50; H, 3.72; N, 8.52.
Bis[2-(N-methylcarbamoyl)phenyl] selenide (8b). 82% yield, colourless needles, m.p. 239.5-242 °C,
1H-NMR (DMSO-d6) δ: 2.84 (d, 6H, J = 4.6 Hz, 2 × CH3), 7.22-7.36 (m, 6H, ArH), 7.57 (d, 2H,
77
J = 6.8 Hz, ArH), 7.93 (bs, 2H, NH); Se-NMR (DMSO-d6) δ: 440; νmax (KBr): 3360, 3319 (NH),
1650, 1626 (CO); Anal. Calcd for C16H16N2O2Se: C, 55.34; H, 4.64; N, 8.07. Found: C, 54.13; H, 4.38;
N, 7.84.
Bis[2-(N-n-propylcarbamoyl)phenyl] selenide (8d). 90% yield, white powder, m.p. 180-182 °C
1
(decomp.), H-NMR (DMSO-d6) δ: 0.88 (t, 6H, J = 7.4 Hz, 2 × CH3), 1.43-1.55 (m, 4H,
2 × CH2CH2CH3), 3.13-3.19 (m, 4H, 2 × CH2CH2CH3), 7.21-7.36 (m, 6H, ArH), 7.53 (d, 2H, J = 7.1
Hz, ArH), 8.42 (t, 2H, J = 5.1 Hz, NH); 77Se-NMR (DMSO-d6) δ: 438; νmax (KBr): 3350, 3261 (NH),
1653, 1627 (CO); Anal. Calcd for C20H24N2O2Se: C, 59.55; H, 6.00; N, 6.94. Found: C, 59.41; H, 6.01;
N, 6.86.
Bis[2-(N-phenylcarbamoyl)phenyl] selenide (8f). 98% yield, white powder, m.p. 238-240 °C
1
(decomp.), H-NMR (DMSO-d6) δ: 7.09 (t, 2H, J = 7.4 Hz, ArH), 7.31-7.35 (m, 6H, ArH), 7.38-7.40
(m, 2H, ArH), 7.42-7.45 (m, 2H, ArH), 7.69-7.72 (m, 6H, ArH), 10.43 (bs, 2H, NH); 77Se-NMR
(DMSO-d6) δ: 434; νmax (KBr): 3310 (NH), 1664 (CO); Anal. Calcd for C26H20N2O2Se: C, 66.24; H,
4.28; N, 5.94. Found: C, 65.70; H, 3.95; N, 5.85.
3.10. Cell cultures
Human lung adenocarcinoma A549 (ATCC 185) cells were maintained in Dulbecco’s modified
Eagle’s medium supplemented with 2 mM L-glutammine, 5% heat-inactivated foetal bovine serum

Molecules 2010, 15
8225
(FBS), 100 U/mL penicilin and 100 µg/mL streptomycin (all from Sigma) at 37 ºC in the atmosphere
of 5% CO2 in air. The cells were plated at a density of 2 × 105 cells/mL on 96-well plates (Costar-
Corning) in 100 µL of fresh media the day before treatment with compounds.
3.11. Virucidal activity assay
The compounds 1-8 at various concentrations (1-1,000 µg/mL) were incubated with following
viruses: HHV-1 (human herpes virus type 1, Herpesviridae, enveloped virus), EMCV
(encephalomyocarditis virus, Picornaviridae, non-enveloped virus) and VSV (vesicular stomatitis
virus, Rhabdoviridae, enveloped virus). Viruses EMCV and VSV were used at the dose of 107
TCID50/mL and HHV-1 at the dose of 105 TCID50/mL. After 1 hour incubation at room temperature,
the virus titer was measured in human cell line A549. Concentration of compound causing 1000 times
decrease of virus titer was taken as minimal inhibitory concentration MIC (µg/mL).
3.12. Cytotoxicity assay
The cytotoxicity of compounds was carried out with human lung adenocarcinoma cell line A549
(ATCC 185). The cells were incubated with serially diluted compounds for 48 hours at 37 ºC in the
atmosphere of 5% CO2 in air. Then, the cultures were observed for cytotoxic effects. The minimal
concentration of compound which was toxic to approximately 50% of cells was taken as TCCD50
(tissue culture cytotoxic dose). Final concentrations of compounds used in virucidal activity assay
were below TCCD50 value that means they were not toxic for the cells.
4. Conclusions
Structural modifications that have been done in the isoselenazol-3(2H)-one ring of
benzisoselenazol-3(2H)-ones 1 allowed us identify the fragment which is necessary for the antiviral
activity of these compounds. The comparison of antiviral properties of benzisoselenazol-3(2H)-ones 1
and their isostructural analogues that do not contain selenium 2–4 clearly indicates the crucial role of
this element for antiviral activity. The replacement of selenium by other atoms or functional groups
drastically diminished the antiviral activity. While benzisoselenazol-3(2H)-ones 1 exhibited high
antiviral activity directed towards HHV-1 and EMCV their non-selenium-containing analogues were
completely inactive 3, 4 or their activity was substantially lower (compounds 2). The possible
mechanism of action probably requires the cleavage of the Se-N bond since compounds having the Se-
C bond instead of it did not exhibit any antiviral activity.
Our study has also demostrated that bis(2-carbamoylphenyl)diselenides 6 that are open-chain
analogues of benzisoselenazol-3(2H)-ones 1 exhibit similar antiviral activity to the cyclic compounds,
whereas the corresponding disulfides 7 and selenides 8 were completely inactive towards the
model viruses.
During our studies on the influence of selenium on antiviral activity a new synthetic approach to
N-substituted isoindolin-1-ones 3 has been elaborated. It has been found that N-acylation of primary
amines by chlorocarbonyl group of 2-(chloromethyl)benzoyl chloride (13), followed by their
N-alkylation in the presence of DBU resulted in the pyrrolidone ring closure. Based on these reactions

Molecules 2010, 15
8226
the simple, general one-pot procedure for synthesis of N-substituted isoindolin-1-ones 3 has
been established.
Acknowledgements
We would like to express our gratitude to Jerzy Palus for providing us with bis(2-carboxyphenyl)
selenide and to Blase Billack, Ewa Zaczynska and Agnieszka Gruszka for valuable advices during
manuscript preparation.
References
1. Mugesh, G.; du Mont, W.W.; Sies, H. Chemistry of biologically important synthetic
organoselenium compounds. Chem. Rev. 2001, 101, 2125-2179.
2. Wojtowicz, H.; Chojnacka, M.; Mlochowski, J.; Palus, J.; Syper, L.; Hudecova, D.; Uher, M.;
Piasecki, E.; Rybka, M. Functionalized alkyl and aryl diselenides as antimicrobial and antiviral
agents: synthesis and properties. Farmaco. Sci. 2003, 58, 1235-1242.
3. Wojtowicz, H.; Kloc, K.; Maliszewska, I.; Mlochowski, J.; Pietka, M.; Piasecki, E. Azaanalogues
of ebselen as antimicrobial and antiviral agents: synthesis and properties. Farmaco. Sci. 2004, 59,
863-868.
4. Pietka-Ottlik, M.; Wojtowicz-Mlochowska, H.; Kolodziejczyk, K.; Piasecki, E.; Mlochowski, J.
New organoselenium compounds active against pathogenic bacteria, fungi and viruses. Chem.
Pharm. Bull. (Tokyo) 2008, 56, 1423-1427.
5. Bhabak, K.P.; Mugesh, G. Amide-based glutathione peroxidase mimics: effect of secondary and
tertiary amide substituents on antioxidant activity. Chem. Asian J. 2009, 4, 974-983.
6. Bhabak, K.P.; Mugesh, G. Synthesis and structure-activity correlation studies of secondary- and
tertiary-amine-based glutathione peroxidase mimics. Chem. Eur. J. 2009, 15, 9846-9854.
7. Mlochowski, J.; Kloc, K.; Syper, L.; Inglot, A.D.; Piasecki, E. Aromatic and azaaromatic
diselenides, benzisoselenazolones and related compounds as immunomodulators active in
humans: synthesis and properties. Liebigs Ann. Chem. 1993, 1239-1244.
8. Palus, J.; Mlochowski, J.; Juchniewicz, L. 2,2’-Diselenobisbenzoates ans 2,2’-diselenobis-
benzenesulfonates: new chiral aryl diselenides. Pol. J. Chem. 1998, 72, 1931-1936.
9. Kloc, K.; Mlochowski, J. Selenenylation-acylation of ketones with 2-chloroselenobenzoyl
chloride. A novel route to benzo[b]selenophenes, Tetrahedron Lett. 2001, 42, 4899-4902.
10. Osajda, M.; Mlochowski, J. The reactions of 2-(chloroseleno)benzoyl chloride with nucleophiles.
Tetrahedron 2002, 58, 7531-7537.
11. Honek, J.F.; Manchini, M.L.; Belleau, B. O-Chlorosulfenylbenzoyl chloride: a useful reagent in
the synthesis of thioxanthones. Synth. Commun. 1983, 13, 997-984.
12. Baggaley, K.H.; English, P.D.; Jennings, J.A.; Morgan, B.; Nunn, B. Inhibitors of blood platelet
aggregation. Effects of some 1,2-benzisothiazol-3-ones on platelet responsiveness to adenosine
diphosphate and collagen. J. Med. Chem. 1985, 28, 1661-1667.
13. Vicini, P.; Amoretti, L.; Ballabeni, V.; Tognolini, M.; Barocelli, E. 2-Amino-Benzo[d]isothiazol-
3-one derivatives: synthesis and assessment of their antiplatelet/spasmolytic effects. Bioorg. Med.
Chem. 2000, 8, 2355-2358.

Molecules 2010, 15
8227
14. Maggiali, C.A.; Mingiardi, M.R.; Branca C. Imidazopyrimidines with cytokinin activity.
Farmaco. Sci. 1983, 38, 935-939.
15. Bordi, F.; Catellani, P.L.; Morini, G.; Plazzi, P.V.; Silva, C.; Barocelli, E.; Chiavarini, M. [4-(3-
Oxo-1,2-benzisothiazolin-2-yl)alkanoic, phenyl and phenoxyalkanoic acids: synthesis and anti-
inflammatory, analgesic, and antipyretic properties. Farmaco. Sci. 1989, 44, 795-807.
16. Mlochowski, J.; Potaczek, P. A simple route to benzo[b]thiophenes: sulfanylation–acylation of
C─H acids with 2-(chlorosulfanyl)benzoyl chloride. Phosphor. Sulfur. Silicon 2009, 184,
1115-1123.
17. Jamil, H.; Gordon, D.A.; Eustice, D.C.; Brooks, C.M.; Dickson, J.K., Jr.; Chen, Y.; Ricci, B.;
Chu, C.H.; Harrity, T.W.; Ciosek, C.P.; Biller, S.A.; Gregg, R.E.; Wetterau, J.R. An inhibitor of
the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells. Proc. Natl.
Acad. Sci. USA 1996, 93, 11991-11995.
18. Guo, Z.; Shultz, A.G. Organic synthesis methodology. Preparation and diastereoselective birch
reduction-alkylation of 3-substituted 2-methyl-2,3-dihydroisoindol-1-ones. J. Org. Chem. 2001,
66, 2154-2157.
19. Kreher, R.P.; Henriqe, H.; Jelitto, F.; Preut, J. Untersuchungen zur chemie von isoindolen und
isoindoleninen. XXXV: 1-Alkoxy-2-alkyl-2H-isoindole
–
o-chinoide hetarene mit
unsymmetrischer struktur. Z. Naturforsch B 1989, 44, 1132-1148.
20. Valenti, P.; Montanari, P.; Da Re, P.; Soldani, G.; Bertelli, A. Synthesis and pharmacological
properties of three lidocaine cyclovinylogues. Arch. Pharm. (Weinheim) 1980, 313, 280-284.
21. Berube, D.; Lessard, J. The mechanism of electrochemical reduction of N-haloamides in
acetonitrile: trapping of intermediate amide anions and father-son protonation1,2. Can. J. Chem.
1982, 60, 1127-1142.
22. Weber, R.; Renson, M. Les chlorures de chloro-3 benzisosélénazolium-1,2: synthèse, hydrolyse,
thiolation, ammonolyse. Bull. Soc. Chim. France 1976, 2, 1124-1126.
23. Mhizha, S.; Mlochowski, J. Synthesis of 2-acyl- and 2-sulfonylbenzisoselenazol-3(2H)-ones.
Synth. Commun. 1997, 27, 283-292.
24. Kamigata, N.; Satoshi, H.; Michio, K.; Hiroshi, N. Photochemical ring-expansion reaction of 1,2-
benzisothiazolinones. Bull. Chem. Soc. Jpn. 1985, 58, 3131-3136.
25. Correa, A.; Tellitu, I.; Dominguez, E.; SanMartin, R. Novel alternative for the N-S bond
formation and its application to the synthesis of benzisothiazol-3-ones. Org. Lett. 2006, 8,
4811-4813.
26. Uchida, Y.; Kozuka, S. The thermal decomposition of N,O-diacyl-N-t-butylhydroxylamines. III.
Novel routes to 2-substituted 1,2-benzoisothiazol-3-(2H)-ones. Bull. Chem. Soc. Jpn. 1982, 55,
1183-1187.
27. Kamigata, N.; Iizuka, H.; Kobayashi, M. Photochemical isomerization of 2-pyridyl- and
2-pyrazinyl-1,2-benzisothiazol-3(2H)-ones. Bull. Chem. Soc. Jpn. 1986, 59, 1601-1602.
28. Burton, D.J.; Koppes W.M. Cleavage of carboxylic acid esters to acid chlorides with
dichlorotriphenylphosphorane. J. Org. Chem. 1975, 40, 3026-3032.
29. Broadus, K.M.; Kass, S.R. Benzocyclobutadienyl anion: formation and energetics of an
antiaromatic molecule. J. Org. Chem. 2000, 65, 6566-6571.

Molecules 2010, 15
8228
30. Anderson, P.S.; Christy, M.E.; Colton, C.D.; Shepard, K.L. A useful synthesis of 3-
oxodihydroisoindoles. J. Org. Chem. 1978, 43, 3719-3723.
31. Orito, K.; Horibata, A.; Nakamura, T.; Ushito, H.; Nagasaki, H.; Yuguchi, M.; Yamashita, S.;
Tokuda, M. Preparation of benzolactams by Pd(OAc)2-catalyzed direct aromatic carbonylation. J.
Am. Chem. Soc. 2004, 126, 14342-14343.
32. Aubert, T.; Farnier, M.; Guilard, R. Nouvelle voie de synthèse d'isoindolones et d'isoquinoléines
par condensation d'iminophosphoranes avec l'ortho-phtalaldéhyde: réactions, mécanismes et étude
structurale. Can. J. Chem. 1990, 68, 842-851.
33. Lessel, J. Benzodiazepine und isoindole durch acylierung von amidinen benzodiazepines and
isoindoles by acylation of amidines. Pharmazie 1993, 48, 812-816.
34. Hartmann, K.H.; Troll, T. Preparation of naphthoquinone imines as nir dyes. Tetrahedron 1995,
51, 4655-4664.
35. Chapman, J.M., Jr.; Cocolas, G.H.; Hall, I.H. Hypolipidemic activity of phtalimide derivatives. 1.
N-substituted phtalimide derivatives. J. Med. Chem. 1979, 22, 1399-1401.
36. Parham, J. Elaboration of bromoarylnitriles. J. Org. Chem. 1976, 41, 1187-1189.
37. Fischer, H.; Dereu, N. Mechanism of the catalytic. reduction of hydroperoxides by ebselen:
A selenium - 77 NMR study. Bull. Soc. Chim. Belg. 1987, 96, 757-768.
38. Nagy, P.; Csampai, A.; Szabo, D.; Varga, J.; Harmat, V.; Ruff, F.; Kucsman, A. Structure and
mechanism of hydrolysis of diaryl(acylamino)(chloro)-λ4-sulfanes and diaryl(acylamino)-
sulfonium salts. J. Chem. Soc., Perkin Trans. 2001, 2, 339-349.
39. Domagala, J.M.; Bader, J.P.; Gogliotti, R.D.; Sanchez, J.P.; Stier, M.A.; Song, Y.; Prasad, J.V.;
Tummino, P.J.; Scholten, J.; Harvey, P.; Holler, T.; Gracheck, S.; Hupe, D.; Rice, W.G.; Schultz,
R. A new class of anti-HIV-1 agents targeted toward the nucleocapsid protein NCp7: the 2,2'-
dithiobisbenzamides. Bioorg. Med. Chem. 1997, 5, 569-579.
40. Gialdi, F.; Ponci, R.; Baruffini, A. Preparation and study of the antifungal activity of o, o’-m, m’-
p,p’-substituted diphenyl disulfides and the corresponding thiophenols. Farmaco. Sci. 1959, 14,
216-239.
41. Lesser, R.; Weiss, R. Über selenhaltige aromatische verbindungen. II. Chem. Ber. 1913, 46,
2640-2658.
Sample Availability: Samples of compounds 1-8 are available from the authors.
© 2010 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article
distributed under the terms and conditions of the Creative Commons Attribution license
(http://creativecommons.org/licenses/by/3.0/).